Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hadar Duskin-Bitan

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 28, 2024
Effectiveness and safety of molnupiravir in the intended-use population: an observational cohort studyWiessam Abu Ahmad, Ronen Arbel, Yael Wolff Sagy, et al.
Indian Journal of Dermatology, Venereology and Leprology|August 19, 2025
Bidirectional association between vitiligo and melasma: A large-scale population-based studyShany Sherman, Hadar Duskin-Bitan, Tamir Agiv, et al.
Infectious Diseases and Therapy|May 10, 2024
Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient GroupsSamah Hayek, Joseph Levy, Galit Shaham, et al.
Infectious Diseases and Therapy|January 6, 2025
Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time PeriodSamah Hayek, Joseph Levy, Galit Shaham, et al.
Nature Medicine|January 31, 2023
Real-world effectiveness of a single dose of mpox vaccine in malesYael Wolff Sagy, Roy Zucker, Ariel Hammerman, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 27, 2023
Risk assessment of human mpox infections: retrospective cohort studyRoy Zucker, Gil Lavie, Yael Wolff-Sagy, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|June 28, 2024
Effectiveness and safety of molnupiravir in the intended-use population: an observational cohort studyWiessam Abu Ahmad, Ronen Arbel, Yael Wolff Sagy, et al.
Indian Journal of Dermatology, Venereology and Leprology|August 19, 2025
Bidirectional association between vitiligo and melasma: A large-scale population-based studyShany Sherman, Hadar Duskin-Bitan, Tamir Agiv, et al.
Infectious Diseases and Therapy|May 10, 2024
Implementation of AZD7442 (Tixagevimab/Cilgavimab) COVID-19 Pre-exposure Prophylaxis (PrEP) in the Largest Health Maintenance Organization in Israel: Real-world Uptake and Sociodemographic and Clinical Characteristics Across Immunocompromised Patient GroupsSamah Hayek, Joseph Levy, Galit Shaham, et al.
Infectious Diseases and Therapy|January 6, 2025
Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time PeriodSamah Hayek, Joseph Levy, Galit Shaham, et al.
Nature Medicine|January 31, 2023
Real-world effectiveness of a single dose of mpox vaccine in malesYael Wolff Sagy, Roy Zucker, Ariel Hammerman, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 27, 2023
Risk assessment of human mpox infections: retrospective cohort studyRoy Zucker, Gil Lavie, Yael Wolff-Sagy, et al.
Pageof 4